Product Information
DOXEPIN 50 MG CAPSULE is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $0.1727 per EA under NDC 71921016401. Its NADAC has been published 186 times since Oct 13, 2021.
FDA first approved this application on Jul 28, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Florida Pharmaceutical Products, LLCNDC
71921016401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213474FDA Approved
7/28/2020
TE Code
AB
On Market Since
5/1/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 50 MG CAPSULE has been published 186 times since Oct 13, 2021, and over the history we have for it it has declined 62.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1727 per EA |
|---|---|
| All-time high | $0.4578 (Oct 13, 2021) |
| All-time low | $0.1165 (Nov 20, 2024) |
| Median price | $0.2728 |
| Average price | $0.2676 |
| Largest weekly change | -37.5% (Nov 20, 2024) |
| Weeks tracked | 186 |
| Tracking since | Oct 13, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-36.1%
5Y
N/A
All
-62.3%
Last surveyed Apr 30, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Florida Pharmaceutical Products, LLC, is $0.1727 per EA (NDC 71921016401), effective Apr 30, 2025.
How has the price of DOXEPIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 62.3%. It has been tracked across 186 weekly CMS publications since Oct 13, 2021.
What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?
Since Oct 13, 2021, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.1165 (Nov 20, 2024) to a high of $0.4578 (Oct 13, 2021), with a median of $0.2728 per EA.
Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN 50 MG CAPSULE, is $0.1535 per EA — about 11% below DOXEPIN 50 MG CAPSULE.
Who manufactures DOXEPIN 50 MG CAPSULE?
DOXEPIN 50 MG CAPSULE (NDC 71921016401) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.